N-Methoxyethyl Erlotinib HCl - Request Quote
N-Methoxyethyl Erlotinib HCl
| SZ CAT No: | SZ-E018013 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 : HCl |
| Mol.Wt. | 451.5 : 36.5 |
| Inv. Status | In Stock |
| Rel. CAS No | 2410548-58-0 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
N-Methoxyethyl Erlotinib HCl is chemically N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-N-(2-methoxyethyl)quinazolin-4-amine hydrochloride. N-Methoxyethyl Erlotinib HCl is supplied with detailed characterization data compliant with regulatory guideline. N-Methoxyethyl Erlotinib HCl can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality N-Methoxyethyl Erlotinib HCl
Purchase N-Methoxyethyl Erlotinib HCl
N-Methoxyethyl Erlotinib HCl suppliers
N-Methoxyethyl Erlotinib HCl manufacturers
N-Methoxyethyl Erlotinib HCl price
Order N-Methoxyethyl Erlotinib HCl
Enquire N-Methoxyethyl Erlotinib HCl
N-Methoxyethyl Erlotinib HCl cost
N-Methoxyethyl Erlotinib HCl Supplier
N-Methoxyethyl Erlotinib HCl Distributor
N-Methoxyethyl Erlotinib HCl for Method Validation
Erlotinib Reference Standard
N-Methoxyethyl Erlotinib HCl for ANDA Filing
N-Methoxyethyl Erlotinib HCl for Forced Degradation Studies
N-Methoxyethyl Erlotinib HCl Identification Standards
N-Methoxyethyl Erlotinib HCl for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.